Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

LUNSUMIO

MOSUNETUZUMAB-AXGB

Standard Dose
30MG/30ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LUNSUMIO is listed in Drugs@FDA under application 761263 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MOSUNETUZUMAB-AXGB Form and strength INJECTABLE;INJECTION - 30MG/30ML Sponsor GENENTECH INC Submission history Latest submission status date: 2025-12-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview LUNSUMIO is listed in Drugs@FDA under application 761263 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient MOSUNETUZUMAB-AXGB Form and strength INJECTABLE;INJECTION - 30MG/30ML Sponsor GENENTECH INC Submission history Latest submission status date: 2025-12-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.